AMLX
Amylyx Pharmaceuticals Inc

2,158
Mkt Cap
$1.53B
Volume
1.57M
52W High
$17.49
52W Low
$3.11
PE Ratio
-8.89
AMLX Fundamentals
Price
$13.81
Prev Close
$14.05
Open
$14.13
50D MA
$14.34
Beta
1.71
Avg. Volume
831,734.41
EPS (Annual)
-$1.53
P/B
4.97
Rev/Employee
$0.00
$831.33
Loading...
Loading...
News
all
press releases
Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Price Expected to Rise, Guggenheim Analyst Says
Guggenheim upped their price target on shares of Amylyx Pharmaceuticals from $25.00 to $30.00 and gave the company a "buy" rating in a research note on Thursday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Maven Securities LTD Makes New $951,000 Investment in Amylyx Pharmaceuticals, Inc. $AMLX
Maven Securities LTD purchased a new stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) during the third quarter, according to the company in its most recent disclosure with the...
MarketBeat·3d ago
News Placeholder
First Light Asset Management LLC Purchases Shares of 3,355,882 Amylyx Pharmaceuticals, Inc. $AMLX
First Light Asset Management LLC purchased a new position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with...
MarketBeat·5d ago
News Placeholder
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Consensus Rating of "Moderate Buy" from Analysts
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) has received an average rating of "Moderate Buy" from the fourteen ratings firms that are covering the company, MarketBeat Ratings...
MarketBeat·5d ago
News Placeholder
Amylyx Pharmaceuticals, Inc. $AMLX Shares Sold by Boxer Capital Management LLC
Boxer Capital Management LLC lessened its stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 26.5% during the third quarter, according to the company in its most recent 13F filing...
MarketBeat·6d ago
News Placeholder
Commodore Capital LP Purchases Shares of 4,075,478 Amylyx Pharmaceuticals, Inc. $AMLX
Commodore Capital LP acquired a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·6d ago
News Placeholder
Braidwell LP Acquires Shares of 612,841 Amylyx Pharmaceuticals, Inc. $AMLX
Braidwell LP bought a new position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange...
MarketBeat·6d ago
News Placeholder
437,391 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Purchased by Ally Bridge Group NY LLC
Ally Bridge Group NY LLC acquired a new position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities...
MarketBeat·6d ago
News Placeholder
Amylyx Pharmaceuticals (NASDAQ:AMLX) Shares Gap Down - Here's What Happened
Amylyx Pharmaceuticals (NASDAQ:AMLX) Shares Gap Down - Should You Sell...
MarketBeat·9d ago
News Placeholder
Amylyx Pharmaceuticals Highlights Avexitide LUCIDITY Phase 3 Enrollment, Q3 Data Timing at Leerink Conf.
Amylyx Pharmaceuticals (NASDAQ:AMLX) co-CEO Justin Klee discussed the company's lead endocrine program, avexitide, and provided updates on its pivotal LUCIDITY trial during a conversation at day two...
MarketBeat·11d ago
<
1
2
...
>

Latest AMLX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.